$469 Million is the total value of SECTOR GAMMA AS's 31 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 32.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $37,760,000 | -39.1% | 677,433 | -29.8% | 8.05% | -18.9% |
| INCY | Buy | INCYTE CORP | $33,143,000 | +34.3% | 452,583 | +60.2% | 7.07% | +78.8% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $31,683,000 | -32.4% | 970,982 | -6.4% | 6.76% | -10.1% |
| ABT | Sell | ABBOTT LABS | $29,223,000 | -40.6% | 370,334 | -34.6% | 6.23% | -20.9% |
| MRK | Buy | MERCK & CO INC | $28,675,000 | -11.1% | 372,695 | +5.0% | 6.11% | +18.3% |
| BIIB | Sell | BIOGEN INC | $23,766,000 | -21.6% | 75,120 | -26.5% | 5.07% | +4.3% |
| PKI | Sell | PERKINELMER INC | $20,967,000 | -29.9% | 278,522 | -9.6% | 4.47% | -6.7% |
| ANTM | Buy | ANTHEM INC | $20,343,000 | -12.0% | 89,602 | +17.1% | 4.34% | +17.2% |
| A | Sell | AGILENT TECHNOLOGIES INC | $18,386,000 | -22.6% | 256,716 | -7.8% | 3.92% | +3.0% |
| PRGO | Buy | PERRIGO CO PLC | $17,132,000 | +21.6% | 356,240 | +30.7% | 3.65% | +61.9% |
| NUVA | Sell | NUVASIVE INC | $15,949,000 | -46.8% | 314,828 | -18.8% | 3.40% | -29.2% |
| JNJ | Buy | JOHNSON & JOHNSON | $15,412,000 | -9.9% | 117,532 | +0.3% | 3.29% | +20.0% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $15,414,000 | +16.2% | 162,554 | +7.9% | 3.29% | +54.6% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $15,130,000 | +10.9% | 168,503 | +33.6% | 3.23% | +47.6% |
| GILD | Sell | GILEAD SCIENCES INC | $14,909,000 | -44.8% | 199,419 | -52.0% | 3.18% | -26.5% |
| HUM | Sell | HUMANA INC | $14,023,000 | -15.5% | 44,657 | -1.3% | 2.99% | +12.5% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $13,025,000 | -0.9% | 275,481 | +26.6% | 2.78% | +31.9% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $11,795,000 | +86.2% | 139,582 | +86.4% | 2.52% | +148.0% |
| BRKR | Sell | BRUKER CORP | $11,721,000 | -32.7% | 326,846 | -4.4% | 2.50% | -10.4% |
| BIO | Sell | BIO RAD LABS INCcl a | $11,383,000 | -31.4% | 32,470 | -27.6% | 2.43% | -8.7% |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $11,234,000 | -12.0% | 501,762 | +15.8% | 2.40% | +17.1% |
| CAH | Sell | CARDINAL HEALTH INC | $9,981,000 | -7.2% | 208,192 | -2.1% | 2.13% | +23.6% |
| DGX | Buy | QUEST DIAGNOSTICS INC | $9,077,000 | +10.4% | 113,042 | +46.9% | 1.94% | +47.0% |
| PDCO | Buy | PATTERSON COS INC | $8,107,000 | -17.1% | 530,217 | +11.1% | 1.73% | +10.4% |
| CVS | New | CVS HEALTH CORP | $7,171,000 | – | 120,860 | +100.0% | 1.53% | – |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $6,446,000 | -29.9% | 145,072 | -32.6% | 1.37% | -6.7% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $5,920,000 | – | 54,384 | +100.0% | 1.26% | – |
| PTCT | Sell | PTC THERAPEUTICS INC | $3,390,000 | -29.6% | 75,996 | -24.2% | 0.72% | -6.2% |
| LIVN | New | LIVANOVA PLC | $3,231,000 | – | 71,400 | +100.0% | 0.69% | – |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $2,392,000 | -43.8% | 376,085 | -8.0% | 0.51% | -25.2% |
| BLUE | Sell | BLUEBIRD BIO INC | $2,229,000 | -59.3% | 48,490 | -22.3% | 0.48% | -45.8% |
| TAK | Exit | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $0 | – | -30,873 | -100.0% | -0.10% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -211,698 | -100.0% | -0.28% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -15,524 | -100.0% | -0.33% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -63,913 | -100.0% | -0.49% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -130,625 | -100.0% | -0.50% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -170,896 | -100.0% | -1.04% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -65,864 | -100.0% | -1.51% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -28,458 | -100.0% | -1.71% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -434,111 | -100.0% | -2.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.